Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (281-290 of 297) with videos related to

Pageof 30
Sort By:
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
Circulation|April 1, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationVallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Annals of the Rheumatic Diseases|March 19, 2017
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosisChikashi Terao, Takahisa Kawaguchi, Philippe Dieude, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African AmericansPravitt Gourh, Elaine F Remmers, Steven E Boyden, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
<i>HLA</i> and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicryPravitt Gourh, Sarah A Safran, Theresa Alexander, et al.
Trials|May 9, 2025
Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR TrialsBrett D Thombs, Claire Adams, Elsa-Lynn Nassar, et al.
Annals of the Rheumatic Diseases|February 5, 2026
Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosisUrvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, et al.
Pageof 30

Showing results (281-290 of 297) with videos related to

Sort By:
Pageof 30
Arthritis Research & Therapy|January 22, 2016
Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patientsMinghua Wu, Shervin Assassi, Gloria A Salazar, et al.
Circulation|April 1, 2009
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension AssociationVallerie V McLaughlin, Stephen L Archer, David B Badesch, et al.
The Lancet. Respiratory Medicine|July 30, 2016
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trialDonald P Tashkin, Michael D Roth, Philip J Clements, et al.
Annals of the Rheumatic Diseases|March 19, 2017
Transethnic meta-analysis identifies <i>GSDMA</i> and <i>PRDM1</i> as susceptibility genes to systemic sclerosisChikashi Terao, Takahisa Kawaguchi, Philippe Dieude, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African AmericansPravitt Gourh, Elaine F Remmers, Steven E Boyden, et al.
Annals of the Rheumatic Diseases|October 5, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Arthritis and Rheumatism|October 15, 2013
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiativeFrank van den Hoogen, Dinesh Khanna, Jaap Fransen, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
<i>HLA</i> and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicryPravitt Gourh, Sarah A Safran, Theresa Alexander, et al.
Trials|May 9, 2025
Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR TrialsBrett D Thombs, Claire Adams, Elsa-Lynn Nassar, et al.
Annals of the Rheumatic Diseases|February 5, 2026
Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosisUrvashi Kaundal, Pei-Suen Tsou, Mousumi Sahu, et al.
Pageof 30